Genscript Biotech says Chinese customs raided offices, shares at 20-month low By Reuters

© Reuters.

HONG KONG (Reuters) – Genscript Biotech Corp (HK:) said customs raided its offices in China in connection with an investigation into suspected violations of import and export regulations, sending the firms’ shares plummeting to a 20-month low.

The Jiangsu-based biotech firm said China’s Customs Anti-Smuggling Department raided its offices in Nanjing and Zhenjiang, and its Chairman Fangliang Zhang is under “residential surveillance”, while four other employees have been detained for questioning.

“The group’s business operations remain normal. The company has taken legal advice as appropriate,” Genscript said, adding it will assist authorities with the investigation, if required.

No charges has been filed against any entity or individual, the company said, adding that Zhang will continue to take part in decision making via appropriate means but is not participating in Genscript’s daily operations.

Zhang is also chairman and chief executive officer of Genscript’s unit Legend Biotech Corp (O:). Legend Biotech has appointed its Chief Financial Officer Ying Huang as interim CEO, the Hong Kong-listed firm added.

Shares of Genscript plunged as much as 27.1% to HK$10.12, their lowest since January 2019, and on track for its worst day since September 2018. The benchmark Hang Seng index () slid 0.3%.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button